Evidence map›Paper›PMID 37255437›Full record

ArticleMicrobiology spectrum2023

Prevalence and Persistence of Antibiotic Resistance Determinants in the Gut of Travelers Returning to the United Kingdom is Associated with Colonization by Pathogenic Escherichia coli.

Timothy J Dallman, Saskia Neuert, Cristina Fernandez Turienzo, Michelle Berin, Emily Richardson, Pablo Fuentes-Utrilla, Nicholas Loman, Saheer Gharbia, Claire Jenkins, Ron H Behrens and 2 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Microbiology and epidemiology of enteroaggregativeJournal of medical microbiology · 2025
    Article
  7. Hybrid strains of enterotoxigenic/Shiga toxin-producingJournal of medical microbiology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Detection ofFrontiers in microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Timothy J DallmanGastrointestinal Bacteria Reference Unit, UK Health Security Agency London, United Kingdom.ORCID 0000-0001-7105-2543
Saskia NeuertGastrointestinal Bacteria Reference Unit, UK Health Security Agency London, United Kingdom.
Cristina Fernandez TurienzoHospital for Tropical Diseases, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Michelle BerinHospital for Tropical Diseases, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Emily RichardsonInstitute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom.
Pablo Fuentes-UtrillaInstitute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom.
Nicholas LomanInstitute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom.
Saheer GharbiaGastrointestinal Bacteria Reference Unit, UK Health Security Agency London, United Kingdom.
Claire JenkinsGastrointestinal Bacteria Reference Unit, UK Health Security Agency London, United Kingdom.
Ron H BehrensHospital for Tropical Diseases, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Gauri GodboleGastrointestinal Bacteria Reference Unit, UK Health Security Agency London, United Kingdom.
Michael BrownHospital for Tropical Diseases, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
University College London Hospitals NHS Foundation Trust · GBUniversity of Birmingham · GBUniversity of Liverpool · GBNational Institute for Health Research · GBUtrecht University · NL

Funding

Department of Health
6 · The paper itself

Abstract

The gut microbiota constitutes an ideal environment for the selection, exchange, and carriage of antibiotic resistance determinants (ARDs), and international travel has been identified as a risk factor for acquisition of resistant organisms. Here, we present a longitudinal metagenomic analysis of the gut resistome in travellers to "high-risk" countries (Gutback). Fifty volunteers, recruited at a travel clinic in London, United Kingdom, provided stool samples before (pre-travel), immediately after (post-travel), and 6 months after their return (follow-up) from a high-risk destination. Fecal DNA was extracted, metagenomic sequencing performed and the resistome profiled. An increase in abundance and diversity of resistome was observed after travel. Significant increases in abundance were seen in antimicrobial genes conferring resistance to macrolides, third-generation cephalosporins, aminoglycosides, and sulfonamides. There was a significant association with increased resistome abundance if the participant experienced diarrhea during travel or took antibiotics, but these two variables were co-correlated. The resistome abundance returned to pre-travel levels by the 6-month sample point but there was evidence of persistence of several ARDs. The post-travel samples had an increase in abundance Escherichia coli which was positively associated with many acquired resistant determinants. Virulence and phylogenetic profiling revealed pathogenic E. coli significantly contributed to this increase abundance. In summary, in this study, foreign travel remains a significant risk factor for acquisition of microbes conferring resistance to multiple classes of antibiotics, often associated with symptomatic exposure to diarrhoeagenic E. coli.

Indexed as

Anti-Bacterial AgentsRespiratory Distress SyndromeDiarrheaDrug Resistance, MicrobialEscherichia coliHumansPhylogenyPrevalenceTravelAnti-Bacterial Agentsantibiotic resistancediarrheaEscherichia coli

Identifiers

PMID37255437
PMCPMC10433802
OpenAlexW4378781183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.